Gainy app creates stock lists and categories depending on NASDAQ Composite and current market information. There is a pool of companies that are always on the list of biotech stocks to buy now. For example, companies from the S&P 500 that are stable and present on the market for many years.
The biotech stocks in this list are already established in the biotech field, most already have commercially successful medicines available and all have considerable market shares in their niche or have great potential to do so in the near future. The companies listed below have mid- to large market caps, so investors can expect the stock prices to keep rising over time.
The biotech companies we recommend looking at are Regeneron, BioNTech, Vertex, Moderna, Gilead Sciences. Even though biotech stocks are not known for paying good dividends, their growth can make up for this. So let’s look at some of the best biotech stocks to buy.
Regeneron Pharmaceuticals, Inc.
Regeneron develops, manufactures and commercializes medicines for a variety of diseases and conditions. It was founded in 1988 and has headquarters in Tarrytown, New York. It is one of the largest biotech companies by market cap and an annual revenue growth of 15.70% over the past 5 years. The company has many collaborations with other key players in the industry.
BioNTech is a biotechnology company based in Mainz, Germany that trades on Nasdaq. BioNTech develops and manufactures modern patient-specific immunotherapies for different diseases, including the Pfizer-BioNTech Covid-19 vaccine.
Vertex focuses on developing and commercializing therapies for treatment of cystic fibrosis (CF). In fact, the company has a near-monopoly in drugs for treatment of CF but works on other diseases as well and has a range of products in the pipeline. The company has a large market capitalization of $48 billion and great revenue growth over the last 5 years.
Moderna came to prominence recently due to the Covid pandemic, when its vaccine became one of the first to be approved for emergency use on the population. Its stock price went from around $20 to $150 in 2020 and kept growing into 2021, closing at $484.47 on August 9. MRNA is the biggest biotech stock in the industry, with a market cap of almost $100 billion. Despite huge sales of its Covid vaccine, the majority of the company’s revenue (60%) comes from grants. It has partnerships with key players in the industry, such as AstraZeneca, Merck, and Vertex.
GILD is a biopharmaceutical firm that makes medicines for a variety of diseases and makes the Covid drug Remdesivir. Their stock price fell at the beginning of October 2021 and is showing good potential for recovery and future growth. This looks like one of the best healthcare stocks to invest in.
Gainy is a stock screener app that can become your handy guide to the world of investing. We offer you the most suitable biotech stocks to own, depending on your investing goals and interests.
The app allows you to create personalized collections such as the best biotech stocks, USA Fintech, or mid-cap stocks. Our analytic toolkit provides each customer with customized information and shows just the stocks they can potentially be interested in. In-app functionality and filters offer the possibility to arrange and customize all needed data in one place. The powerful search helps to find out everything about any biotech stock, ETF, cryptocurrency, investment idea, and collections that users like to invest in.
Gainy website is all about education. We know that traders always need information, so we created FAQ, Knowledge Base, and Blog. FAQ allows users to get any brief details on the market and stocks; any “How to” & “What if” questions are here. Knowledge Base is guidance filled with relevant knowledge that is always in demand. Our blog contains the latest market updates and information all traders worldwide can be interested in.
We know that successful investment is always about the knowledge of which stocks to buy and when. This especially applies to the biotech industry, which can be volatile and unpredictable. So the in-app function analyzes and highlights customized information depending on personal goals, finance possibilities, and risk profile and recommends suitable categories, stocks, ETFs or cryptocurrencies to invest in.
Updates & fluctuations focus on the latest market situation, global changes, and their analysis. Investors should understand market trends and move along with them to make profits.
In share market trend analysis, it’s essential to pick the sector and collect all the needed data, for example, about the best biotech stocks. Traders take external and internal information that affects the sector and attempt to predict the direction the market moves.
There are some points an investor should understand:
In the beginning, investors do not always understand the sense behind the stock market trading trend and cannot consider all the nuances, and here robotic apps can help. Gainy automatically analyzes all the data a stakeholder needs to invest and offers the best possible solutions to profit.